An Unrecognizable Campaign
Passage Bio | FTD-GRN
The Ask
Create a website and surround sound campaign to bolster Passage Bio’s clinical trial enrollment efforts for their investigational gene therapy candidate that can potentially halt or slow the progression of FTD-GRN, a fatal, genetic neurodegenerative disease affecting the frontotemporal lobes of the brain.
The Results
Created both an HCP and patient clinical trial site. The HCP site displayed below includes information about the disease state, the gene therapy candidate, clinical trial information, drivers to sponsored free genetic testing sites, and a decision tree to further make it clear to clinicians if their patients are eligible. The programmatic banners drove to the HCP site and capitalized on the theme of degeneration by distorting patient portraits.
Since launching the banners, audience engagement with the clinical trial site more than doubled and time spent on the site grew by 65%.
Art Director: Caroline Grew. FTD=frontotemporal dementia caused by a GRN mutation; HCP=healthcare professional.
